Aurobindo launches $1.6b bid to buy Novartis generics unit

Aurobindo launches $1.6b bid to buy Novartis generics unit

Aurobindo Pharma. Photo: Bloomberg

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter